Pricing Log in Create free account

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs Gain Therapeutics, Inc. (GANX)

Connect Biopharma Holdings Limited Sponsored ADR and Gain Therapeutics, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and Gain Therapeutics, Inc. are of similar size ($58.1M and $57.1M). Gain Therapeutics, Inc. has the higher net margin (0.00% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Connect Biopharma Holdings Limited Sponsored ADR leads on 8 and Gain Therapeutics, Inc. on 7.

Valuation

Metric CNTB GANX Biotechnology median
P/E n/m n/m 8.50
P/S 19.07 276.65 9.71
P/B 2.13 4.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.64 211.41 9.21
Earnings yield (130.77%) (39.68%) (33.15%)
Free cash flow yield (106.62%) (35.12%) (25.50%)

Profitability

Metric CNTB GANX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (2,346.35%) 0.00% 0.00%
Net margin (2,298.93%) 0.00% 0.00%
Free cash flow margin (2,018.76%) 0.00% 0.00%
Return on equity (140.51%) (268.30%) (56.36%)
Return on assets (109.34%) (159.22%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTB GANX Biotechnology median
Revenue growth (TTM) — 18.36% 6.02%
EPS growth (last fiscal year) (257.14%) 31.46% 30.26%
Revenue growth, 5-year CAGR — 21.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTB GANX Biotechnology median
Debt to equity 0.01 0.03 0.00
Current ratio 2.37 4.36 4.72
Net debt to EBITDA 0.77 1.10 0.96

Dividend

Metric CNTB GANX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTB GANX Biotechnology median
Market cap 57.06m 58.05m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack